论文部分内容阅读
目的 了解我国林可霉素注射剂的药物利用以及影响因素。方法 药物利用研究选取1997年2001年全国林可霉素注射剂产量的资料和两家综合性医院的处方,对林可霉素的使用情况进行分析。结果全国林可霉素注射剂的产量较大,每年约10亿支左右。从两家综合性医院的处方分析来看,二级医院的使用量远远大于三级甲等医院(分别是1个月383 张处方和3个月123 张处方),且大剂量静脉使用量二级医院也 远远大于三级甲等医院。结论 林可霉素注射液在全国用量较大,且超过规定剂量使用较普遍,尤其是在级别较低的医院。
Objective To understand the drug utilization and influencing factors of lincomycin injection in China. Methods Drug Use Study Select the national lincomycin injection production in 1997 and the prescriptions of two general hospitals to analyze the use of lincomycin. Results National Lincomycin injection production larger, about 1 billion per year or so. From the analysis of prescriptions in two general hospitals, the usage of secondary hospitals is much larger than that of tertiary hospitals (383 prescriptions in one month and 123 prescriptions in three months respectively), and the use of high-dose intravenous Two hospitals are also far greater than the three first-class hospitals. Conclusions Lincomycin injection is widely used throughout the country and is more common than the prescribed dose, especially in lower-grade hospitals.